{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:11:11Z","timestamp":1779289871017,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sociedade Brasileira de Reumatologia","award":["----"],"award-info":[{"award-number":["----"]}]},{"name":"Sociedad Argentina de Reumatologia","award":["---"],"award-info":[{"award-number":["---"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10067-019-04516-2","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T11:04:27Z","timestamp":1556017467000},"page":"2129-2139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR"],"prefix":"10.1007","volume":"38","author":[{"name":"on behalf of the BIOBADABRASIL study group, Sociedade Brasileira de Reumatologia and of the BIOBADASAR study group, Sociedad Argentina de Reumatologia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6855-2413","authenticated-orcid":false,"given":"Roberto","family":"Ranza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Celina","family":"de la Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ieda Maria Magalh\u00e3es","family":"Laurindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eca Gimena","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Cezar","family":"Titton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Brigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Ranzolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Granel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Cappuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Quinteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Luiz Shinji","family":"Hayata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Smichowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngela Luzia Branco P.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Stadler","family":"Kahlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina S\u00e1nchez","family":"Andia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claiton Viegas","family":"Brenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson","family":"Velozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Mussano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique R.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges Basile","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo","family":"da Rocha Castelar Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gl\u00e1ucio Ricardo Werner","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen Mary","family":"da Silveira Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Elena","family":"Exeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas Guimar\u00e3es","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Petkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanio Alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izaias Pereira","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Eduardo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Roberto Silva","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio Cesar Bertacini","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel Barros","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Al\u00edcia","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de F\u00e1tima Lobato C.","family":"da Sauma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"de Medeiros Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f4nica Val\u00e9ria Siqueira Santana","family":"de Vechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo Luis","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Astesana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Finucci","family":"Curi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Louzada-Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reginaldo Botelho","family":"Teodoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Acayaba","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia","family":"Papasidero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vander","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Saurit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Washington Alves","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rog\u00e9rio","family":"de Melo Costa Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Descalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jesus","family":"Gomez-Reino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"issue":"6","key":"4516_CR1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/annrheumdis-2016-210708","volume":"76","author":"S Ramiro","year":"2017","unstructured":"Ramiro S, Sepriano A, Chatzidionysiou K, Nam JL, Smolen JS, van der Haijde D et al (2017) Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 76(6):1101\u20131136","journal-title":"Ann Rheum Dis"},{"key":"4516_CR2","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1136\/ard.2009.118018","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R et al (2010) EULAR points to consider when establishing, analysing and reporting safety data of biologics registries in rheumatology. Ann Rheum Dis 69:1569\u20131602","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 85","key":"4516_CR3","first-page":"S163","volume":"32","author":"L Carmona","year":"2014","unstructured":"Carmona L, de la Vega M, Ranza R, Casado G, Titton DC, Descalzo MA et al (2014) BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries. Clin Exp Rheumatol 32(Suppl. 85):S163\u2013S167","journal-title":"Clin Exp Rheumatol"},{"key":"4516_CR4","first-page":"145","volume":"52","author":"D Titton","year":"2011","unstructured":"Titton D, Silveira IG, Louzada JP, Hayata AL, Carvalho HMS, Ranza R et al (2011) Brazilian biologic registry: BiobadaBrasil implementation process and preliminary results. Rev Bras Reumatol 52:145\u2013160","journal-title":"Rev Bras Reumatol"},{"issue":"4","key":"4516_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.47196\/rar.v24i4.43","volume":"24","author":"M Vega de la","year":"2013","unstructured":"de la Vega M, Gomez G, Casado C, Battagliotti C, Exeni I, Gobbi C et al (2013) Tercer reporte de eventos adversos con tratamientos biol\u00f3gicos en Argentina. Informe de registro BIOBADASAR. Revista Argentina de Reumatologia 24(4):8\u201314","journal-title":"Revista Argentina de Reumatologia"},{"key":"4516_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/ard.2008.091926","volume":"68","author":"A Zink","year":"2009","unstructured":"Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DPM (2009) European biologicals registers: methodology, selected results and perspectives. Ann Rheum Dis 68:1240\u20131246","journal-title":"Ann Rheum Dis"},{"key":"4516_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semarthrit.2010.03.003","volume":"40","author":"JR Curtis","year":"2010","unstructured":"Curtis JR, Jain A, Askling J, Bridges SL Jr, Carmona L, Dixon W, Finckh A, Hyrich K, Greenberg JD, Kremer J, Listing J, Michaud K, Mikuls T, Shadick N, Solomon DH, Weinblatt ME, Wolfe F, Zink A (2010) A comparison of patients characteristics and outcomes in selected European and US rheumatoid arthritis registries. Semin Arthritis Rheum 40:2\u201314","journal-title":"Semin Arthritis Rheum"},{"key":"4516_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semarthrit.2010.09.004","volume":"41","author":"C Pease","year":"2011","unstructured":"Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Carter Thorne J et al (2011) Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patients parameters at initiation of anti-TNF therapy. Semin Arthritis Rheum 41:81\u201389","journal-title":"Semin Arthritis Rheum"},{"key":"4516_CR9","doi-asserted-by":"publisher","unstructured":"Cecconi M, Ranza R, Titton D, Moraes JCB, Bertolo MB, Bianchi W et al (2018; online first) Incidence of infectious adverse events in patients with rheumatoid arthritis and spondyloarthritis on biologic drugs\u2014data from the Brazilian registry for biologics monitoring. J Clin Rheumatol. https:\/\/doi.org\/10.1097\/RHU0000000000000935","DOI":"10.1097\/RHU0000000000000935"},{"key":"4516_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42358-018-0005-0","volume":"58","author":"LMH Mota da","year":"2018","unstructured":"da Mota LMH, Kakehasi AM, APM G, Pereira IA, Rezende-Fronza LS, Bertolo MB et al (2018) 2017 Recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of Rheumatoid Arthritis. Advances in Rheumatology 58:2","journal-title":"Advances in Rheumatology"},{"key":"4516_CR11","unstructured":"Actualizacion de las guias de practica clinica en el tratamiento de la Artritis Reumatoidea - Grupo de estudio de artritis reumatoidea - Sociedad Argentina de Reumatologia 2013. online: http:\/\/www.reumatologia.org.ar\/docs\/guias_sar_2013.pdf ,"},{"key":"4516_CR12","doi-asserted-by":"publisher","unstructured":"Ramiro S, Sepriano A, Chatzidionysiou K, Nam JL, Smolen JS, van der Haijde D et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis Ann Rheum Dis Published Online First: March 15,2017. Online supplement - https:\/\/doi.org\/10.1136\/annrheumdis-2016-210708","DOI":"10.1136\/annrheumdis-2016-210708"},{"key":"4516_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00296-014-2945-y","volume":"34","author":"T Cobo-Ib\u00e1\u00f1ez","year":"2014","unstructured":"Cobo-Ib\u00e1\u00f1ez T, Descalzo MA, Loza-Santamar\u00eda E, Carmona L, Munoz-Fernandes S (2014) Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0. Rheumatol Int 34:953\u2013961","journal-title":"Rheumatol Int"},{"key":"4516_CR14","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3899\/jrheum.101009","volume":"38","author":"Y Komano","year":"2011","unstructured":"Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H, Nakajima A, Saito K, Takeno M, Atsumi T, Tohma S, Ito S, Tamura N, Fujii T, Sawada T, Ida H, Hashiramoto A, Koike T, Ishigatsubo Y, Eguchi K, Tanaka Y, Takeuchi T, Miyasaka N, Harigai M, REAL Study Group (2011) Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Long-term Safety. J Rheumatol 38:1258\u20131264","journal-title":"J Rheumatol"},{"key":"4516_CR15","first-page":"27","volume":"21","author":"JV Miranda","year":"2014","unstructured":"Miranda JV, Pe\u00f1aranda LFP, Grajales CM, Hernandez JDM, Padilla LMR, Franco CJV (2014) Infections in rheumatoid arthritis patients: biological therapy versus disease modifying anti-rheumatic drugs: one year follow-up. Rev Colomb Reumatol 21:27\u201334","journal-title":"Rev Colomb Reumatol"},{"key":"4516_CR16","first-page":"216","volume":"33","author":"CE Lampropoulos","year":"2015","unstructured":"Lampropoulos CE, Orfanos P, Bournia VK, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG (2015) Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol 33:216\u2013224","journal-title":"Clin Exp Rheumatol"},{"key":"4516_CR17","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52:3403\u20133412","journal-title":"Arthritis Rheum"},{"key":"4516_CR18","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, British Society for Rheumatology Register Control Centre Consortium, Silman BJ et al (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving antitumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54:2368\u20132376","journal-title":"Arthritis Rheum"},{"key":"4516_CR19","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1002\/art.22808","volume":"56","author":"WG Dixon","year":"2007","unstructured":"Dixon WG, Symmons DPM, Lunt M, Watson KM, Hyrich KL (2007) British Society for Rheumatology Register Control Centre Consortium et al. Serious infection following anti\u2013tumor necrosis factor\u2014therapy in patients with rheumatoid arthritis. Arthritis Rheum 56:2896\u20132904","journal-title":"Arthritis Rheum"},{"key":"4516_CR20","unstructured":"WHO Global Tuberculosis Report 2016. World Health Organization. WHO\/HTM\/TB\/2016.13,"},{"key":"4516_CR21","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3899\/jrheum.150057","volume":"42","author":"JW Ai","year":"2015","unstructured":"Ai JW, Zhang S, Ruan QL, Yu YQ, Zhang BY, Lin QH et al (2015) The risk of tuberculosis in patients with rheumatoid arthritis treated with tumor necrosis factor-\u03b1 antagonist: a metaanalysis of both randomized controlled trials and registry\/cohort studies. J Rheumatol 42:2229\u20132237","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"4516_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rbr.2017.05.003","volume":"57","author":"CL Yonekura","year":"2017","unstructured":"Yonekura CL, Oliveira RDR, Titton DC, Ranza R, Ranzolin A, Hayata AL et al (2017) Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitora\u00e7\u00e3o de Terapias Biol\u00f3gicas \u2013 BIOBADABRASIL). Rev Bras Reumatol Engl Ed 57(Suppl 2):477\u2013483","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"4516_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1590\/0074-02760150235","volume":"110","author":"CMF Gomes","year":"2015","unstructured":"Gomes CMF, Terreri MT, Moraes-Pinto MI, Barbosa C, Machado NP, Melo MR (2015) Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline\u2014a longitudinal analysis after using TNFa blockers. Mem Inst Oswaldo Cruz 110:921\u2013928","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4516_CR24","unstructured":"WHO Global leprosy update, 2015: time for action, accountability and inclusion. No 35, 2016, 91, 405-20,"},{"issue":"3","key":"4516_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1590\/S0482-50042010000300013","volume":"50","author":"DS Freitas","year":"2010","unstructured":"Freitas DS, Machado N, Andrigueti FV, Ruis Neto ET, Pinheiro MM (2010) Hansen\u00edase virchowiana associada ao uso de inibidor do fator de necrose tumoral \u03b1: relato de caso. Rev Bras Reumatol 50(3):333\u2013339","journal-title":"Rev Bras Reumatol"},{"key":"4516_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jbspin.2013.07.009","volume":"81","author":"H Che","year":"2014","unstructured":"Che H, Lukas C, Morel J, Combe B (2014) Risk of herpes\/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis. Joint Bone Spine 81:215\u2013221","journal-title":"Joint Bone Spine"},{"key":"4516_CR27","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1136\/annrheumdis-2016-209131","volume":"75","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Xie F, Yun H, Bernatsky S, Winthrop KL (2016) Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis. Ann Rheum Dis 75:1843\u20131847","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4516_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/art.22504","volume":"56","author":"JR Curtis","year":"2007","unstructured":"Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, Shatin D, Saag KG (2007) Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor \u221d antagonists. Arthritis Rheum 56(4):1125\u20131133","journal-title":"Arthritis Rheum"},{"key":"4516_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP, BSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register (2011) Anti-TNF therapy is associated with an increased risk of serious infection in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risk in the elderly. Rheumatology 50:124\u2013131","journal-title":"Rheumatology"},{"issue":"12","key":"4516_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.medcli.2010.11.032","volume":"137","author":"MJ Perez-Sola","year":"2011","unstructured":"Perez-Sola MJ, Torre-Cisneros J, Perez-Zafrilla B, Carmona L, Descalzo MA, Gomez-Reino JJ et al (2011) Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Med Clin 137(12):533\u2013540","journal-title":"Med Clin"},{"key":"4516_CR31","first-page":"905","volume":"77","author":"AI Rutheford","year":"2018","unstructured":"Rutheford AI, Subesinghe S, Hyrich KL, Galloway JB (2018) Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 77:905\u2013910","journal-title":"Ann Rheum Dis"},{"key":"4516_CR32","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1136\/ard.2011.151043","volume":"70","author":"A Strangfeld","year":"2011","unstructured":"Strangfeld A, Eveslage M, Schneider M, Bergerhausen HJ, Klopsch T, Zink A, Listing J (2011) Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 70:1914\u20131920","journal-title":"Ann Rheum Dis"},{"key":"4516_CR33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/ard.2006.062760","volume":"66","author":"J Askling","year":"2007","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Felklius N et al (2007) Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis 66:1339\u20131344","journal-title":"Ann Rheum Dis"},{"key":"4516_CR34","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00296-014-3045-8","volume":"34","author":"R Sakai","year":"2014","unstructured":"Sakai R, Cho SK, Nanki T, Koike R, Watanabe K, Yamazaki H et al (2014) The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database. Rheumatol Int 34:1729\u20131736","journal-title":"Rheumatol Int"},{"key":"4516_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/BOR.0b013e3282f4b392","volume":"20","author":"J Askling","year":"2008","unstructured":"Askling J, Dixon W (2008) The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Curr Opin Rheumatol 20:138\u2013144","journal-title":"Curr Opin Rheumatol"},{"key":"4516_CR36","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/rheumatology\/kes413","volume":"52","author":"SAA Dartel Van","year":"2012","unstructured":"Van Dartel SAA, Fransen J, Kievt W, Dutmer EAJ, Brus HLM, Houtman NM et al (2012) Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Rheumatology 52:1052\u20131057","journal-title":"Rheumatology"},{"key":"4516_CR37","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46:2294\u20132300","journal-title":"Arthritis Rheum"},{"key":"4516_CR38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10067-015-2929-7","volume":"34","author":"BP Faf\u00e1","year":"2015","unstructured":"Faf\u00e1 BP, Louzada-Junior P, Titton DC, Zandonade E, Ranza R, Laurindo I et al (2015) Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL. Clin Rheumatol 34:921\u2013927","journal-title":"Clin Rheumatol"},{"key":"4516_CR39","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/annrheumdis-2015-207838","volume":"75","author":"A Richter","year":"2016","unstructured":"Richter A, Listing J, Schneider M, Klopsch T, Kapelle A, Kaufmann J, Zink A, Strangfeld A (2016) Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis. Ann Rheum Dis 75:1667\u20131673","journal-title":"Ann Rheum Dis"},{"key":"4516_CR40","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3899\/jrheum.150166","volume":"42","author":"FA Pinheiro","year":"2015","unstructured":"Pinheiro FA, Souza DCC, Sato EI (2015) A study of multiple causes of death in rheumatoid arthritis. J Rheumatol 42:2221\u20132228","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T16:15:25Z","timestamp":1663344925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4516"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04516-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"6 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors are members of the respective national rheumatological society. All authors declare to have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics committees of the leading centres in Brazil and Argentina (Curitiba and Buenos Aires) approved the study. Each site obtained the approval of local ethics committee. All patients signed an informed consent prior to inclusion in the registries.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}